Investor Alert- Freddie & Fannie Record Profits !!

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Alert-Freddie & Fannie Record Profits !!
( Final Version 2 )

WSJ - March 13, 2014 / 3:22 PM ET

Bloomberg Business News - March 13, 2014 / 5:57 PM ET
Crapo Crab Interview ! ( Friday March 14th Crapo Proposal Dead !! )

The Street - March 14, 2014 / 6:00 AM ET

Ralph Nader‘s Comment of March 12th :
The Crapo Crab as proposal, not of any agreement, at
Congress has NO chance same as the former last one.
Freddie & Fannie are doing a very good Job and have
Records Profits. The Contract Conditions by The Gov.
made and forced Freddie & Fanny to sign are Illegal
and Unconstitutional. Resulting As The Court Will Now
Soon Correcting The Conditions To Become Legal Once
and Freddie & Fanny again to have the Chance to get
again a Private Company by some adjustments may
need for not repeating the past problems got into.
Nader already at Friday March 14, 2014 got confirmed
as to be right, by the Crapo Proposal Only also not
possible to be presented to the Congress, because not
even written in the essential Legal Language to present.
This already confirms well the kind of Amateur Status
the Crapo Crab Brothers have with its fantasies only.
In the Situation anything declared as „MURKY“ is by
the Obama Administration only, because they MOB like
Crooks & Co. did press force Freddie & Fanny to sign
Illegal & Unconstitutional Contract Conditions to keep
this well in mind.
One has to imagine, the US Gov. made some Bailout as
Help when needed, but illegally never allowed Freddie &
Fanny to payback the Bail- Amount under the knowledge
of how profitable Freddie & Fannie are and they at end
of March 2014 by Dividends & Profits handed to the
US Gov. already as Legally Correct paid more than the
US Gov. ever provided. The criminal handling of US Gov.
just based on keeping Freddie & Fanny as the Democrats
Obama Administration Piggy- Bank for anything else the
US Gov. may has to pay for, but not to Freddie & Fanny
related. This Will Drastically Affect The Democrats Party !!


CONCLUSIVE :
By Freddie & Fanny one also need to keep in mind, that
they presently are the Worlds Most Profitable Companies !
Taking all the above under consequent considerations means,
the presently about 20 well recommended Capital Institutions
which Sued The US Gov. knows very well Why & What & When
they do and how successful by the criminal mistakes of the
Obama Administration, they definitely finally going to be !!
Even the timing to Sue the US Gov. could have never been
better since Freddie & Fanny paid back even more than
legally correct it suppose to be, by strait explanations.

Now maybe some also wondering, why under the last week
scenario in all the Medias, from the US Gov. Suing Parties
only was none of any Comment To Hear or See, it has a
very simple explanation, because they as well known act
strategically by not creating or supporting Attraction for
the Stocks, for themselves to be able „To Buy As Much
As Possible At Cheapest Prices !! “, which could also be
seen as reconfirmed by the Hugh- Buying Pressure under
the Falling- Scenario last Week where often „The Bid As
Higher Than The Ask !! “ Did Prove Everything.

We can also soon expect the Court Actions Starting and
the resulting Last Attempt by the US Gov. to influence
The Judge to dismiss all about 20 Court Applications,
by the Judge got wisely Dismissed to start Procedures
As Necessary !! There is no way out for the US Gov. !

This Above For Every Investor To Think Well About !

It’s the Gov. which made Illegal Things To Be Aware
Of and without any luck now did trying to escape !!


For The Happy FNMA & FMCC Investing Only


.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading